Long non-coding RNAs as novel therapeutic targets in cancer

Research output: Contribution to journalReview articlepeer-review


Thanks to impressive technology advancements, pervasive expression of non-coding RNAs (ncRNAs) has been recently identified in the genome of numerous cancers. Long ncRNAs (lncRNAs) belong to a new class of ncRNAs including tens of thousands different species. A fraction of these molecules shows a striking cancer-enriched expression pattern, suggesting an essential role in tumor cells and, possibly, a utility in therapeutic terms. This review aims at summarizing current knowledge for the identification and validation of lncRNAs as therapeutics targets in tumors. Both in-silico and wet-biology resources are presented in relation to the many challenges that the scientific community still needs to address in terms of lncRNA identification, stratification, patient personalization, drug delivery and toxicity.

Original languageEnglish
Pages (from-to)131-138
Number of pages8
JournalPharmacological Research
Publication statusPublished - Aug 1 2016


  • Apoptosis
  • Bioinformatics
  • Cancer
  • Drug delivery
  • ncRNA

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Long non-coding RNAs as novel therapeutic targets in cancer'. Together they form a unique fingerprint.

Cite this